Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis. (Sinusitis)
Effect of Low Level Laser Therapy on Headache, and Fatigue in Patients With Chronic Rhinosinusitis.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Chronic sinusitis, or chronic rhinosinusitis, is an inflammatory condition defined by symptomatic inflammation of the paranasal sinuses lasting longer than 3 months. Common presenting symptoms include nasal obstruction, facial pressure or fullness, nasal discharge (anterior or posterior), and olfactory loss. Furthermore, chronic sinusitis is associated with reductions in patient quality of life (QOL), sleep quality, and daily productivity.
It has been suggested that low-level laser can be used in treating chronic sinusitis but there are limited studies about its usage.
HYPOTHESES:
There is no statistically significant effect of laser therapy on headache, fatigue, or CT finding in patients with chronic sinusitis.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dokki
-
Giza, Dokki, Egypt, 12611
- Olfat Ibrahim Ali
-
Giza, Dokki, Egypt, 12611
- Faculty of Physical Therapy, Cairo University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients suffering from mild to moderate symptoms.
Exclusion Criteria:
- Pregnant or breastfeeding women
- Patients with a definite deviated nasal septum, sinusitis, or history of operation within the last 6 months.
- Patients with hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, infection, active respiratory disease like asthma, or other systemic diseases; • patients with long-term use of corticosteroids or immunosuppressive agents.
- Patients with hypersensitivity to the laser.
- Patients who were involved in another clinical study within 30 days.
- Patients who were unable to comply with the follow-up schedules.
- patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks, and other drugs whi
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Study group
The participants were treated using LLLT (904nm and 2.5 J/ sinus) for one month
|
participants were randomized into either the LLLT group or sham treatment group by a computer-generated random number.
The participants were treated using LLLT (904nm and 2.5 J/ sinus).
treatment was delivered for one month
|
|
Sham Comparator: Control group
using LLLT without output adjustment of the parameters
|
participants were randomized into either the LLLT group or sham treatment group by a computer-generated random number.
The participants were treated using LLLT (904nm and 2.5 J/ sinus).
treatment was delivered for one month
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Headache
Time Frame: Baseline
|
Headache was measured using headache scale at the beginning and end of the intervention.
The scale ranged from zero to 10.
The higher the scale the higher the headache
|
Baseline
|
|
Headache
Time Frame: One month
|
Headache was measured using headache scale at the beginning and end of the intervention.
The scale ranged from zero to 10.
The higher the scale the higher the headache
|
One month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatigue
Time Frame: Baseline
|
Fatigue was measured using fatigue scale at the beginning and end of the intervention.
The scale ranged from zero to 10.
The higher the scale the higher the fatigue value.
|
Baseline
|
|
Fatigue
Time Frame: One month
|
Fatigue was measured using fatigue scale at the beginning and end of the intervention.
The scale ranged from zero to 10.
The higher the scale the higher the fatigue value.
|
One month
|
|
Ct finding
Time Frame: Baseline
|
number of sinus opacifications before and after intervention.
|
Baseline
|
|
Ct finding
Time Frame: One month
|
number of sinus opacifications before and after intervention.
|
One month
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Olfat I Ali, PhD, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Chronic rhinosinusitis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.